Optical Transcutaneous Sensors of Capnia and Oxygenation
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Jun 19, 2019
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males or females between 18 and 50 year old
- • Individual having health insurance
- • Individual able to provided informed consent
- • Subjects with no known pathology and not taking any medical treatment a priori capable of interfering with controlled hypoxia at levels required in the protocol
- Exclusion Criteria:
- • Body mass index \>27 kg/m²
- • History of acute mountain sickness
- • Chronic diseases know to be associated with high methemoglobinemia
- • Known allergy to one of the materials used in the devices (lycra, polyamide...), or to the adhesive plaster.
- • Active smoker (\>3 cigarets/day)
- • Alcohol consumption (\>10g/day)
- • Individual with high skin sensitivity due to skin diseases
- • Mental disorders
- • Persons who refuse to sign the information sheet and participation agreement
- • Persons under guardianship or not subject to a social security system
- • Pregnant woman, parturient, breastfeeding mother
- • Person deprived of liberty by judicial or administrative decision
- • A person who is subject to a legal protection measure that cannot be included in clinical trials.
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grenoble, Rhône Alpes, France
Patients applied
Trial Officials
Stéphane Doutreleau, MD PhD
Principal Investigator
Grenoble Alpes Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials